Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease

Medical Decision Making

Volumn 21, Issue 1, 2001, Pages 28-36

  Bogart, Laura M ^a,b   Catz, Sheryl L ^b   Kelly, Jeffrey A ^b   Benotsch, Eric G ^b  

^a KENT STATE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Adherence; Antiretroviral treatment; Attitudes; HIV AIDS; Medical decision making

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; TREATMENT INDICATION;

EID: 0035085440     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X0102100104     Document Type: Article

References (38)

1. Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society-USA panel
2. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents
3. Incidence and predictors of virological failure of indinavir and/or ritonavir in an urban health clinic
4. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
5. Self-reported adherence to HAART and correlation with HIV RNA: Initial results with the patient medication adherence questionnaire
6. A randomized, double-blind trial comparing combinations of nevirapine, didanosinc, and zidouvdine for HIV-infected patients
7. Public health implications of antiretroviral therapy and HIV drug resistance
8. HIV-1 drug resistance in newly-infected individuals
9. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors
10. Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine
11. Reduced antiretroviral drug susceptibility among patients with primary HIV infection
12. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued?
13. Protease inhibitor use among a community sample of people with HIV disease
14. Physician concurrence with primary care guidelines for persons living with HIV disease
15. Variations in the care of HIV-infected adults in the United States: Results from the HIV cost and services utilization study
16. The safety and efficacy of zidovudine (AZT) in treatment of patients with mildly symptomatic human immunodeficiency virus (HIV) infection
17. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic
18. A critical review of the "determinants" of patient compliance with therapeutic regimens
19. The impact of medical and nonmedical factors on physician decision-making for HIV/AIDS antiretroviral treatment
20. The rate of adoption of new procedures among physicians
21. Practice setting and physician influences on judgments of colon cancer treatment by community physicians
22. Patient, physician, and presentational influences on clinical decision-making for breast cancer: Results from a factorial experiment
23. Physician characteristics associated with the decision to withdraw life support
24. Physician practice style and rates of hospitalization for chronic medical conditions
25. The role of attitudes, beliefs, and personal characteristics of Italian physicians in the surgical treatment of early breast cancer
26. AIDS in women in the United States: Recent trends
27. Sex differences in HIV-1 viral load and progression to AIDS
28. Nonresponse to mailed surveys: A review and guide
29. Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The advanced HIV disease ritonavir study group
30. Nonadherence in tuberculosis treatment: Predictors and consequences in New York City
31. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance
32. Psychiatric morbidity, illicit drug use, and adherence to zidovudine (AZT) among injection drug users with HIV disease
33. When should we delay highly active antiretroviral therapy?
34. Implications of HIV treatment advances for behavioral research on AIDS: Protease inhibitors and new challenges in HIV secondary prevention
35. Judging 'current disease activity' in rheumatoid arthritis - An international comparison
36. Clinical judgment in rheumatoid arthritis: I. Rheumatologists' opinions and the development of 'paper patients'
37. Criterion validity of responses to patient vignettes: An analysis based on management of female urinary incontinence